Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.39 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.38 |
| ▸ | CYP11B2 | P19099 | 4/20 | 0.38 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.38 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | RPS6KB1 | P23443 | 5/20 | 0.36 |
| ▸ | AKT1 | P31749 | 5/20 | 0.36 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.36 |
| ▸ | PRKDC | P78527 | 1/20 | 0.35 |
| ▸ | SCN10A | Q9Y5Y9 | 2/20 | 0.35 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21453057 | 0.88 | RPS6KB1 (0.42) | HRH4GRM2CYP11B2CYP11B1RPS6KB1 | |
| SCHEMBL21453061 | 0.85 | HRH4 (0.39) | HRH4GRM2KDM4EHTTLRRK2 | |
| SCHEMBL21452872 | 0.85 | HRH4 (0.39) | HRH4GRM2KDM4EHTTLRRK2 | |
| SCHEMBL21452873 | 0.84 | CYP11B2 (0.41) | HRH4CYP11B2CYP11B1KDM4ERPS6KB1 | |
| SCHEMBL21453060 | 0.78 | CYP11B1 (0.41) | HRH4GRM2CYP11B2CYP11B1NOTUM | |
| SCHEMBL21434084 | 0.76 | ITGB2 (0.45) | HRH4CYP11B2CYP11B1 | |
| SCHEMBL21453056 | 0.73 | PDE2A (0.38) | HRH4GRM2LRRK2 | |
| SCHEMBL21452938 | 0.72 | MAPK1 (0.39) | HRH4GRM2KDM4E | |
| SCHEMBL23515046 | 0.71 | HRH4 (0.45) | HRH4KDM4EHTTPRKDC | |
| SCHEMBL18991731 | 0.71 | KDM4E (0.49) | GRM2TLR7KDM4EHTTSCN10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019193516-A2 | SUBSTITUTED PYRIDINE AND PYRIMIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2019-10-10 | — | — | WO | disclosed |